title: Aldose reductase pathway contributes to vulnerability of aging myocardium to ischemic injury.
abstract: Aging men and women display both increased incidence of cardiovascular disease and complications of myocardial infarction and heart failure. We hypothesized that altered glucose metabolism, in particular, flux of glucose via the polyol pathway (PP) may be responsible, in part, for the enhanced vulnerability of aging myocardium to ischemic injury, even in the absence of superimposed disease processes linked to PP flux, such as diabetes. To test our hypothesis, we determined the expression and products of PP enzymes aldose reductase (AR) and sorbitol dehydrogenase (SDH) in hearts from Fischer 344 aged (26 months) and young (4 months) rats subjected to global ischemia followed by reperfusion in the presence or absence of blockers of PP and the measures of ischemic injury and functional recovery were determined. Expression and activities of AR and SDH were significantly higher in aged vs. young hearts, and induction of ischemia further increased AR and SDH activity in the aged hearts. Myocardial ischemic injury was significantly greater in aged vs. young hearts, and blockade of AR reduced ischemic injury and improved cardiac functional recovery on reperfusion in aged hearts. These data indicate that innate increases in activity of the PP enzymes augment myocardial vulnerability to I/R injury in aging, and that blockers of PP protect the vulnerable aging hearts.
authors: Diabetes Research Program, Department of Medicine, New York University Langone Medical Center, New York, NY 10016, USA.
authors: Radha
authors: R
authors: Ananthakrishnan
authors: Qing
authors: Q
authors: Li
authors: Teodoro
authors: T
authors: Gomes
authors: Ann Marie
authors: AM
authors: Schmidt
authors: Ravichandran
authors: R
authors: Ramasamy
references: Am J Physiol. 1995 Mar;268(3 Pt 2):H935-44
references: 7900892
references: Cardiovasc Res. 1997 Feb;33(2):243-57
references: 9074687
references: Prog Cardiovasc Dis. 1989 Nov-Dec;32(3):217-38
references: 2682779
references: Free Radic Biol Med. 2000 Jul 1;29(1):17-25
references: 10962201
references: N Engl J Med. 1992 Dec 10;327(24):1735-9
references: 1304738
references: Am J Physiol. 1998 Jul;275(1):H75-83
references: 9688898
references: Diabetes. 1997 Feb;46(2):292-300
references: 9000707
references: J Am Coll Cardiol. 2003 Jan 15;41(2):293-9
references: 12535825
references: Cardiovasc Diabetol. 2008 Oct 28;7:33
references: 18957123
references: J Thorac Cardiovasc Surg. 1992 Jan;103(1):60-4; discussion 64-5
references: 1728715
references: J Clin Invest. 2005 Sep;115(9):2434-43
references: 16127462
references: FASEB J. 2005 May;19(7):795-7
references: 15746188
references: Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1447-52
references: 11009428
references: Am J Physiol. 1998 Jul;275(1):H195-203
references: 9688914
references: Cardiovasc Res. 1999 Apr;42(1):130-9
references: 10435004
references: J Mol Cell Cardiol. 1998 Jul;30(7):1415-30
references: 9710809
references: Free Radic Biol Med. 2008 Sep 1;45(5):602-10
references: 18549825
references: Circ Res. 1990 Jan;66(1):135-46
references: 2295135
references: Circ Res. 1994 May;74(5):817-28
references: 8156629
references: Exp Gerontol. 1999 Aug;34(5):699-714
references: 10530794
references: Circulation. 2003 Jan 21;107(2):346-54
references: 12538439
references: Circ Res. 1993 Jan;72(1):112-25
references: 8380259
references: Am J Physiol Heart Circ Physiol. 2001 Jul;281(1):H290-7
references: 11406496
references: J Appl Physiol (1985). 1994 Jan;76(1):328-32
references: 8175525
references: Am J Cardiol. 1998 Sep 3;82(5A):54K-60K
references: 9737487
references: Bioorg Med Chem. 2003 Sep 15;11(19):4179-88
references: 12951149
references: Diabetes. 2006 Jul;55(7):1946-53
references: 16804062
references: Circulation. 2006 Oct 24;114(17):1838-46
references: 17030682
references: Cardiovasc Res. 1993 Dec;27(12):2222-8
references: 8313432
references: Cardiovasc Res. 2009 Jul 15;83(2):247-61
references: 19176601
references: Circ Res. 1988 Dec;63(6):1036-43
references: 3197271
references: J Mol Cell Cardiol. 2005 Feb;38(2):245-56
references: 15698831
references: Circ Res. 2002 Aug 9;91(3):240-6
references: 12169650
references: Nephron Exp Nephrol. 2004;98(3):e89-99
references: 15528949
references: Circulation. 2003 Jan 7;107(1):139-46
references: 12515756
references: J Med Chem. 1991 Jan;34(1):108-22
references: 1899452
references: Cardiovasc Res. 2002 Dec;56(3):443-53
references: 12445885
references: J Lab Clin Med. 1994 Dec;124(6):843-51
references: 7798799
references: Circulation. 1997 Jan 21;95(2):313-5
references: 9008441
references: FASEB J. 2003 Dec;17(15):2331-3
references: 14525943
references: Annu Rev Physiol. 1974;36:413-59
references: 19400669
references: Heart Fail Rev. 2002 Jan;7(1):63-9
references: 11790923
references: Circulation. 2003 Jan 28;107(3):490-7
references: 12551876
references: J Pharmacol Sci. 2006 Sep;102(1):37-46
references: 16936455
references: Mech Ageing Dev. 1999 Dec 7;112(1):5-25
references: 10656180
references: Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H333-41
references: 19060123
references: J Gerontol. 1993 Jul;48(4):B168-70
references: 8315221
references: FASEB J. 2002 Feb;16(2):243-5
references: 11772943
references: J Biol Chem. 2008 Apr 4;283(14):9101-12
references: 18223294
references: FASEB J. 2004 Aug;18(11):1192-9
references: 15284219